Dyne Therapeutics, Inc. ( DYN) - Stock Earnings
DYN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
DYN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -112.0 million USD | — USD |
| 2026Q1 | -120.9 million USD | — USD |
| 2026Q2 | -178.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
DYN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -235.9 million USD | — USD |
| 2024 | -317.4 million USD | — USD |
| 2025 | -446.2 million USD | — USD |
| 2026 Est. | — | — |
DYN
Price: $14.25
52 week price:
Earnings Per Share: -3.28 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 169300
Ebitda: 950.0 millionMarket Capitalization: 2.9 billion